Josh Sokol

1 month ago | auntminnieeurope.com | Chris Hammond |Philip Ward |Josh Sokol |Edna Astbury-Ward

Micro-ultrasound may be a suitable alternative to MRI for predicting pathological tumor volume in prostate cancer lesions, according to Swiss research published on 13 March in Urologic Oncology: Seminars and Original Investigations. Dr. Arnas Rakauskas, a urologist and clinical fellow in robotic surgery from Lausanne University Hospital, and colleagues found that while micro-ultrasound can predict prostate volume more accurately than MRI, the latter can identify more tumors.

1 month ago | auntminnieeurope.com | Chris Hammond |Philip Ward |Josh Sokol |Edna Astbury-Ward

Fluoroscopy-assisted ultrasound guidance for mini-percutaneous nephrolithotomy (mini-PCNL) procedures in children is a safer and more effective approach than fluoroscopy alone, researchers have found. The results suggest that there's a way to treat children with kidney stones with lower radiation doses, wrote a team led by Dr. Amr Salama of the Alexandria School of Medicine in Egypt. The group's research was published on 13 March in Urology.

1 month ago | auntminnieeurope.com | Chris Hammond |Philip Ward |Josh Sokol |Edna Astbury-Ward

Health New Zealand has responded to a month-long wait time for a woman's ultrasound results, indicating the problem involved staff shortages, the New Zealand Herald reported. The health agency said results should have been provided within seven to 10 days for the New Plymouth patient -- a radiographer -- who was advised by her general practitioner (GP) that she needed a “semiurgent” pelvic ultrasound, the Herald explained.

2 months ago | auntminnie.com | Amerigo Allegretto |Josh Sokol

Lung ultrasound (LUS) scoring is reliable for determining whether preterm newborns need surfactant for suspected respiratory distress syndrome (RDS), a study published February 19 in Pediatrics & Neonatology found.

2 months ago | auntminnie.com | Amerigo Allegretto |Josh Sokol |Philip Ward

Combined endobronchial ultrasound and endoscopic ultrasound (CUS) is a reliable tool for ruling out N2 disease in PET-negative lung cancer patients, researchers have reported. Researchers led by Błażej Kużdżał, MD, from the Maria Skłodowska-Curie National Institute of Oncology in Cracow, Poland found that while N2 disease prevalence in PET-negative mediastinal lymph nodes is low, CUS achieved a high negative predictive value (NPV) in assessing the presence of N2 disease.